Original Article

Journal of Investigative Dermatology (1994) 102, 89–92; doi:10.1111/1523-1747.ep12371738

Quantification of Cellular Proliferation in Acne Using the Monoclonal Antibody Ki-67

Helen E Knaggs1, Diana B Holland1, Chris Morris1, Edward J Wood2 and William J Cunliffe1

  1. 1Department of Dermatology, The General Infirmary, Leeds, England
  2. 2Department of Biochemistry and Molecular Biology, University of Leeds, Leeds, England

Received 5 May 1993; Accepted 2 September 1993.

Top

Abstract

The mechanism by which ductal hypercornification occurs in acne is uncertain. We investigated proliferation in normal and acne follicles and in the interfollicular epidermis using the monoclonal antibody Ki-67, which reacts with a nuclear antigen expressed by cells in the G1, S, M, and G2 phases of the cell cycle. Cryostat sections of biopsies from the interscapular region from acne patients and from normal volunteers were stained with Ki-67 antibody and counterstained with 2% methyl green. The number of Ki-67-positive nuclei in the basal layer were counted and expressed as a percentage of the total number of basal nuclei in the ductal or interfollicular epithelia. The data was expressed as mean percent plusminus SD. In normal follicles from acne-affected sites 17.40% plusminus 1.86% (n = 8) of the nuclei were Ki-67 positive. This was significantly higher (p <0.01) than follicles from an area of skin unaffected by acne (11.01% plusminus 6.16%, n = 8). In the follicular epithelia of non-inflamed lesions, the percentage of Ki-67 positive nuclei was 23.44% plusminus 8.36% (n = 15). It was impossible to count the nuclei of follicular epithelium of inflamed lesions because little of this remained intact. In normal interfollicular epidermis, Ki-67-positive nuclei represented 5.33% plusminus 3.36% (n = 8) of the total. This value was not significantly different from the value obtained for interfollicular epidermis near non-inflamed lesions (10.46% plusminus 4.45%, n = 15). However, the number of Ki- 67-positive nuclei in the interfollicular epidermis near inflamed lesions was significantly higher than either of these two values: 25.26% plusminus 6.83%, n = 13, p < 0.05. Our results with Ki-67 confirm that ductal hyperproliferation occurs in acne and shows that normal follicles from acne skin may be "acne-prone."

Keywords:

duct, follicular, keratinocyte, immunohistochemistry

Top

References

  1. Cunliffe, WJ: Acne 1989 Martin Dunitz, London,
  2. Plewig, G, Fulton, JE, Kligman, AM: Cellular dynamics of comedo formation in acne vulgaris. Arch Dermatol Forsch 1971 242: 12–29,  | Article | PubMed | ISI | ChemPort |
  3. Kligman, AM: An overview of acne. J Invest Dermatol 1974 117: 268–287,
  4. Schwartz, PM, Milstone, LM: Thymidine phosphorylase in human keratinocytes. Biochem Pharmacol 1988 37: 353–355,
  5. Davison, P, Liu, S, Karasek, M: Limitations in the use of 3H-thymidine incorporation into DNA as an indicator of epidermal keratinocytes proliferation in vitro. Cell Tissue Kinet 1979 12: 605–614,
  6. Schwartz, PM, Kugelman, LC, Coifman, Y, Hough, LM, Milstone, LM: Human keratinocytes catabolise thymidine. J Invest Dermatol 1988 90: 8–12,
  7. Schaer, J-C, Maurer, U, Schindler, R: Determination of thymidine in serum used for cell culture media. Exp Cell Biol 1978 46: 1–10,
  8. Peehl, DM, Ham, RG: Clonal growth of human keratinocytes with small amounts of dialyzed serum. In Vitro 1980 16: 526–538,
  9. Kornberg, A: Biosynthesis of DNA precursors. In: Kornberg A (ed.). DNA replication 1980, WH Freeman and Company, New York, pp 39–85,
  10. Schwartz, PM, Barnett, SK, Reuveni, H: Thymidine salvage changes with differentiation in human keratinocytes in vitro. J Invest Dermatol 1991 97: 1057–1060,
  11. Watt, FM, Boukamp, P, Hormung, J, Fusenig, NE: Effect of growth environment on spatial expression of involucrin by human epidermal keratinocytes. Arch Dermatol Res 1987 279: 335–340,  | Article | PubMed | ISI | ChemPort |
  12. Gerdes, J, Schwab, U, Lemke, H, Stein, H: Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 6 1983 31: 13–20,
  13. Gerdes, J, Lemke, H, Baisch, H, Wackcer, H, Schwab, U, Stein, H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984 133: 1710–1715,  | PubMed | ISI | ChemPort |
  14. Gerdes, J: Growth fractions in breast cancer determined in situ with monoclonal antibody Ki-67. J Clin Pathol 1986 39: 977–980,
  15. Burke, BM, Cunliffe, WJ: The assessment of acne vulgaris—the Leeds technique. Br J Dermatol 1984 111: 83–92,  | PubMed | ISI | ChemPort |
  16. French, RG, Roundhill, J, Hughes, D, Holgate, C, Jackson, P, Loney, D, Wyatt, S: Histochemistry Laboratory Manual 1983 University of Leeds,
  17. Franklin, WA, McDonald, GB, Stein, HO, Gatter, KC, Jewell, DP, Clarkc, LC, Mason, DY: Immunohistologic demonstration of abnormal colonic crypt cell kinetics in ulcerative colitis. Hum Pathol 1985 16: 1129–1132,  | PubMed | ChemPort |
  18. Epstein, WL, Maibach, HI: Cell renewal in human epidermis. Arch Dermatol 1965 92: 462–468,  | Article | PubMed | ISI | ChemPort |
  19. Shahrad, P, Marks, R: Hair follicle kinetics in psoriasis. Br J Dermatol 1976 94: 7–12,
  20. Soyer, HP, Smolle, J, Smolle-Juettner, FM, Kerl, H: Proliferation antigens in cutaneous melanocytic tumours—an immunohistochemical study comparing the transferrin receptor and the Ki-67 antigen. Dermatologica 1989 179: 3–9,
  21. Gelfant, S: The cell cycle in psoriasis: a reappraisal. Br J Dermatol 1976 95: 577–590,
  22. Rijzewik, JJ, Erp, PEJ, Bauer, FW: Two binding sites for Ki-67 related to quiescent and cycling cells in human epidermis. Acts Dermatol Venereal (Stockh) 1989 69: 512–515,
  23. Weinstein, GD, McCullough, JL: Cytokinetics in diseases of epidermal hyperplasia. Annu Rev Med 1973 24: 345–352,
  24. Allegra, F, Panfilis, G: An in vivo method of studying the kinetics of cell proliferation in normal human epidermis. Acta Dermatol Venereol (Stockh) 1974 54: 87–90,
  25. Eisen, AZ, Holyoke, JB, Lobitx, WC: Responses of the superficial portion of the human piloscbaceous apparatus to controlled injury. J Invest Dermatol 1955 25: 145–156,  | PubMed | ISI | ChemPort |
  26. Rupniak, HT, Turner, DM, Cunliffe, WJ, Dhuna, R, West, MR: Cell envelope production in acne. In: Marks R, Plewig G (eds.). Acne and Related Disorders 1989 Martin Dunitz, London, pp 87–93,
  27. Holmes, RL, Williams, M, Cunliffe, WJ: Pilosebaceous duct obstruction and acne. Br J Dermatol 1972 87: 327–332,  | PubMed | ISI | ChemPort |
  28. Schellander, F, Marks, R: The epidermal response to subepidermal inflammation. Br J Dermatol 1973 88: 363–397,
  29. Downing, DT, Stewart, ME, Wertz, PW, Strauss, JS: Essential fatty acids and acne. J Am Acad Dermatol 1986 14: 221–225,  | PubMed | ISI | ChemPort |
  30. Morello, AM, Downing, DT, Strauss, JS: Octadecadienoic acids in the skin surface lipids of acne patients and normal subjects. J Invest Dermatol 1976 66: 319–323,
  31. Choudry, R, Hodgins, MB, Kwast, TH, Brinkmann, AO, Boersma, WJA: Localisation of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. J Endocrinol 1992 133: 467–475,  | PubMed |
  32. Eady, EA, Ingham, E, Walters, CE, Cove, JH, Cunliffe, WJ: Modulation of comedonal IL-1 levels in acne patients treated with tetracycline. J Invest Dermatol 1993 101: 86–91,

Extra navigation

.
ADVERTISEMENT